Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study

被引：0
|
作者：
Kazuhide Kawase
Jason L. Vittitow
Robert N. Weinreb
Makoto Araie
机构：
[1] Gifu University Hospital,Clinical Affairs
[2] Bausch + Lomb,Department of Ophthalmology and Shiley Eye Institute, Hamilton Glaucoma Center
[3] University of California San Diego,undefined
[4] Kanto Central Hospital of The Mutual Aid Association of Public School Teachers,undefined
来源：
Advances in Therapy | 2016年 / 33卷
关键词：
Intraocular pressure; Nitric oxide; Ocular hypertension; Open-angle glaucoma; Ophthalmology; Prostaglandin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1612 / 1627
页数：15
相关论文
共 50 条
  • [21] Phase III safety and efficacy study of long-term brinzolamide/timolol fixed combination in Japanese patients with open-angle glaucoma or ocular hypertension
    Nakajima, Masayuki
    Iwasaki, Naoki
    Adachi, Masaki
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 149 - 156
  • [22] Latanoprostene Bunod 0.024% Significantly Reduces and Maintains Mean Diurnal Intra-Ocular Pressure (IOP) Compared to Latanoprost 0.005% in Subjects with Open Angle Glaucoma or Ocular Hypertension
    Katz, L. Jay
    Kaufman, Paul
    Ong, Tuyen
    Scassellati-Sforzolini, Baldo
    Vittitow, Jason
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [23] The long-term safety and efficacy of brinzolamide 1.0% (Azopt) in patients with primary open-angle glaucoma or ocular hypertension
    March, WF
    Ochsner, KI
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2000, 129 (02) : 136 - 143
  • [24] LATANOPROSTENE BUNOD FOR THE TREATMENT OF OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION: SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS
    Royer, C.
    Beauchemin, C.
    Lachaine, J.
    Cui, A.
    Gervais, Jobin K.
    Barbeau, M.
    VALUE IN HEALTH, 2019, 22 : S363 - S363
  • [25] Efficacy of Latanoprostene Bunod Ophthalmic Solution 0.024% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Lowering IOP over 24 hours in Subjects With Open Angle Glaucoma or Ocular Hypertension (CONSTELLATION)
    Liu, John H. K.
    Vittitow, Jason L.
    Ngumah, Quintus
    Weinreb, Robert N.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [26] The long-term safety and efficacy of timolol maleate gel forming solution in patients with open-angle glaucoma or ocular hypertension
    Silver, LH
    Garadi, R
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S513 - S513
  • [27] Retrospective Chart Review on Real-World Use of Latanoprostene Bunod 0.024% in Treatment-Naive Patients with Open-Angle Glaucoma
    Okeke, Constance O.
    Burstein, Eitan S.
    Trubnik, Valerie
    Deom, James E.
    Cooper, Michael S.
    Brinkley, Desirae A.
    Thimons, J. James
    Kabiri, Alexander J.
    Gelb, Kerry M.
    OPHTHALMOLOGY AND THERAPY, 2020, 9 (04) : 1041 - 1053
  • [28] A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
    Weinreb, Robert N.
    Ong, Tuyen
    Sforzolini, Baldo Scassellati
    Vittitow, Jason L.
    Singh, Kuldev
    Kaufman, Paul L.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (06) : 738 - 745
  • [29] Latanoprostene Bunod 0.024% w/v Treatment of Open-anlge Glaucoma: Short-term Effects, Safety, and Changes in Ocular Blood Flow
    Kim, Hyun Woo
    Lee, Chong Eun
    Seo, Sam
    Lee, Kyoo Won
    Lee, Chang Hoon
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2023, 64 (10): : 930 - 938
  • [30] Retrospective Chart Review on Real-World Use of Latanoprostene Bunod 0.024% in Treatment-Naïve Patients with Open-Angle Glaucoma
    Constance O. Okeke
    Eitan S. Burstein
    Valerie Trubnik
    James E. Deom
    Michael S. Cooper
    Desirae A. Brinkley
    J. James Thimons
    Alexander J. Kabiri
    Kerry M. Gelb
    Ophthalmology and Therapy, 2020, 9 : 1041 - 1053
12345